Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 79,600
+1,100 (1.40%)
At close: Dec 30, 2025
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 6.53 trillion as of December 30, 2025. Its market cap has increased by 368.43% in one year.
Market Cap
6.53T
Enterprise Value
6.49T
Revenue
5.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
79,600.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 6.53T, an increase of 153.39%. That is a compound annual growth rate of 12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 6.53T | 253.59% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |